Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD), a leading global cause of chronic liver disease, encompasses a wide spectrum of disease stages from isolated hepatic steatosis to cirrhosis. After decades of limited therapeutic options, pivotal... ...
